Hemodynamic monitoring: Key market research findings
- Growing focus on emote hemodynamic monitoring
- Consumable to generate overall revenue of $2 billion in the coming years
Technavio has released a new market research report on the global hemodynamic monitoring market, which is expected to grow at a CAGR of more than 6% between 2016 and 2020. Medical facilities use hemodynamic monitoring to measure various vital signs of people in a critical state and the perioperative and post-operative conditions of individuals admitted to ICUs. Currently, most of the vendors are developing non-invasive devices, as they help minimize catheter-related bloodstream infections and reduce hospital stay and medical expenses. The Americas is the largest revenue-contributing region in the global hemodynamic monitoring market, accounting for 46% of the total market share. Much of this region’s growth comes from the massive purchase of hemodynamic monitoring systems and consumables to monitor individuals with life-threatening conditions.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“Of late, the vendors are developing new remote monitoring hemodynamic devices to improve management and advanced patient monitoring associated with LVADs. It has been observed that remote hemodynamic monitoring can improve LVAD management by assisting in pump speed optimization and remotely monitoring cardiovascular hemodynamics such as cardiac index and detection of heart failure. Moreover, physicians also use non-invasive hemodynamic monitoring for obese people undergoing surgeries. The rise in the incidence of cardiovascular diseases and obesity will further lead to the demand for remote monitoring over the next four years,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research
The hemodynamic monitoring devices by consumables leads this market, accounting for 74% of the total market share. The market is growing rapidly with the sales of hemodynamic consumables such as sensors and catheters. The physicians are using invasive central venous hemodynamic monitoring as a standard care to achieve better results and analysis of the condition. This segment is expected to generate revenues worth $844.2 million by 2020.
The leading vendors in the global hemodynamic monitoring market include Edwards Lifesciences, LiDCO, ICU Medical, and PULSION Medical Systems. This market has significant growth opportunities for the vendors, owing to its huge growth potential. The global vendors along with other prominent vendors collaborate with group purchasing organizations to distribute their products worldwide and increase their market share by receiving long-term contracts from hospitals.
A more detailed analysis is available in the Technavio report, Global Hemodynamic Monitoring Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
Global Ambulatory Blood Pressure Monitoring Systems Market 2016-2020
